Our Pricing

Understanding Mounjaro Pricing in the UK: What You Need to Know

Published on: June 03, 2026

Mounjaro pricing varies significantly across UK pharmacies, making it essential to compare costs before starting treatment. As a UK-registered pharmacy, we've helped thousands of patients access tirzepatide at transparent, competitive rates. This guide explains the factors affecting Mounjaro costs, how to find genuine savings, and what to expect when purchasing this prescription weight loss medication.

What Determines Mounjaro Pricing in UK Pharmacies?

Mounjaro pricing in the UK depends on several factors including dose strength, prescription requirements, and pharmacy operational costs. Tirzepatide, the active ingredient in Mounjaro, is a relatively new medication approved by the MHRA in 2023, and pricing reflects both manufacturing complexity and regulatory compliance standards[1]. Unlike NHS prescriptions with fixed charges, private prescriptions allow pharmacies to set their own pricing structures.

The most significant cost driver is the dose strength prescribed. Mounjaro is available in six strengths—2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg—with higher doses typically commanding higher prices due to increased active pharmaceutical ingredient content. At Cured Pharmacy, we maintain transparent Mounjaro pricing starting from £124.99, with first-time customers saving £124.99 using code Weightlossnew, bringing the effective cost to £124.99[2].

Pharmacy registration status, clinical oversight costs, and dispensing standards also influence pricing. As a GPhC-registered pharmacy (9012511) under superintendent pharmacist Tarun Kumar (GPhC 2233073), our pricing reflects the genuine cost of UK-licensed medication, clinical assessment by registered prescribers, and compliance with stringent pharmaceutical regulations. Beware of significantly cheaper sources that may not meet UK regulatory standards.

Mounjaro Pricing Across Different Dose Strengths

Understanding Mounjaro pricing by dose strength helps patients budget for their complete treatment journey. Clinical protocols typically start patients on 2.5mg for four weeks, then escalate to 5mg, 7.5mg, 10mg, 12.5mg, and finally 15mg based on tolerance and weight loss response[3]. Each dose escalation represents a new prescription and associated cost.

At Cured Pharmacy, our Mounjaro pricing structure remains consistent across dose strengths at £124.99 per four-week supply, with the £20 discount code Weightlossnew available for first orders. This transparent pricing model means patients can accurately forecast their monthly medication costs without hidden fees or surprise charges. The SURPASS-1 trial demonstrated that higher doses (10mg and 15mg) produced greater weight reduction—up to 22.5% body weight loss over 72 weeks—but require gradual titration through lower doses first[4].

Calculating Your Total Mounjaro Pricing Over Treatment Duration

Most patients remain on Mounjaro for 6-12 months to achieve and maintain significant weight loss, making long-term Mounjaro pricing considerations important. A typical patient might spend four weeks each on 2.5mg, 5mg, 7.5mg, and 10mg doses before reaching their maintenance dose—representing at least four months of treatment. At our pricing of £124.99 per month (£124.99 for first order with discount code), a six-month treatment course costs approximately £124.99.

This transparent pricing approach contrasts with some pharmacies that charge variable rates depending on dose strength or bundle consultations separately. Our clinical assessment is included, conducted by UK-registered prescribers who review your medical history, current medications, and weight loss goals to determine appropriate Mounjaro dosing. All prescription medications require this clinical approval before dispensing.

Comparing Mounjaro Pricing to Alternative Weight Loss Treatments

When evaluating Mounjaro pricing, many patients compare it to alternative GLP-1 receptor agonists and weight loss medications available in the UK. Wegovy (semaglutide) typically costs from £124.99 monthly, whilst Saxenda (liraglutide) starts from £124.99, making tirzepatide a premium option. However, clinical trial data suggests Mounjaro may deliver superior weight loss outcomes, with SURPASS-2 showing tirzepatide 15mg produced 5.5kg more weight loss than semaglutide 1mg over 40 weeks[5].

The cost-effectiveness of Mounjaro pricing becomes clearer when examining efficacy per pound spent. In the SURMOUNT-1 trial, participants on tirzepatide 15mg lost an average of 22.5% of their body weight compared to 2.4% with placebo—representing substantial clinical benefit that may justify the higher price point for suitable patients[6]. Oral options like Wegovy tablets (from £124.99) and Orlistat (from £124.99) offer lower-cost alternatives, though with different mechanisms and efficacy profiles.

When Mounjaro Pricing Represents Better Value Than Alternatives

For patients with BMI ≥35 kg/m² or ≥30 kg/m² with weight-related comorbidities who haven't achieved adequate results with other medications, Mounjaro pricing may represent superior value despite higher upfront costs. The dual GIP/GLP-1 receptor agonist mechanism produces more pronounced appetite suppression and metabolic effects than single-pathway medications[7]. Patients who reach their goal weight faster may ultimately spend less overall compared to longer courses of less effective treatments.

Our transparent Mounjaro pricing at £124.99 monthly (£124.99 first order with code Weightlossnew) includes all clinical oversight, prescription services, and discreet delivery. We never charge hidden consultation fees or membership subscriptions, ensuring the price you see is the price you pay. All treatments require assessment by our UK-registered clinical team to ensure safety and appropriateness.

How to Access the Cheapest Mounjaro Pricing in the UK

Finding legitimate low Mounjaro pricing requires verifying pharmacy credentials and understanding what's included in quoted prices. Always confirm the pharmacy is GPhC-registered—you can verify our registration (9012511) on the General Pharmaceutical Council website. Genuine UK-licensed Mounjaro should never be available without prescription, and suspiciously low pricing often indicates counterfeit medication or unregistered suppliers.

At Cured Pharmacy, we guarantee the cheapest legitimate Mounjaro pricing in the UK at £124.99, reduced to £124.99 for first-time customers using discount code Weightlossnew. This includes free online consultation under three minutes, assessment by UK-registered prescribers, genuine Eli Lilly manufactured Mounjaro KwikPens, and discreet next-day delivery. Our superintendent pharmacist Tarun Kumar oversees all dispensing to ensure pharmaceutical standards.

Beware of pricing that seems too good to be true. The wholesale cost of Mounjaro means legitimate pharmacies cannot sustainably offer prices significantly below £124.99-150 monthly whilst maintaining regulatory compliance, proper clinical oversight, and genuine medication sourcing. International websites offering lower Mounjaro pricing may supply unlicensed versions not approved by the MHRA, potentially compromising safety and efficacy.

Understanding What's Included in Mounjaro Pricing

Transparent Mounjaro pricing should clearly itemise what services and products you receive. At Cured Pharmacy, our £124.99 price (£124.99 with first-order discount code Weightlossnew) includes the complete four-week supply of Mounjaro KwikPens, full clinical assessment by UK-registered prescribers, prescription issuance, pharmaceutical dispensing oversight by our superintendent pharmacist, and discreet delivery to your UK address.

Some pharmacies advertise low headline Mounjaro pricing but add consultation fees (£124.99-40), prescription charges, delivery costs, or membership subscriptions that inflate the true price. We believe in upfront transparency—the price displayed is your total cost with no hidden extras. Our clinical team reviews your medical history, current medications, blood pressure, and weight loss goals to determine if Mounjaro is appropriate, with assessment results typically available within hours.

Each Mounjaro prescription covers a four-week treatment period with four single-use KwikPens (one weekly injection). Our Mounjaro pricing includes all necessary injection supplies, though patients should have sharps disposal containers. Follow-up prescriptions require brief clinical review to monitor progress and side effects, ensuring ongoing safety throughout your weight loss journey. All prescription medications require prescriber approval based on individual clinical suitability.

Mounjaro Pricing and Insurance Coverage

Mounjaro is not currently available via NHS prescription for weight management, meaning patients must access it privately. Private medical insurance policies vary in their coverage of weight loss medications—some insurers cover Mounjaro pricing partially or fully for patients with documented obesity and related health conditions, whilst others exclude weight management treatments entirely. Check your specific policy terms or contact your insurer directly.

For self-paying patients, our Mounjaro pricing of £124.99 monthly (£124.99 first order with discount code Weightlossnew) represents a manageable investment in health for many individuals. We recommend budgeting for at least six months of treatment to achieve meaningful results, based on clinical trial protocols. Payment is required before dispensing, and we accept all major credit and debit cards through secure payment processing.

Future Mounjaro Pricing Trends and Availability

Mounjaro pricing in the UK market may evolve as competition increases and manufacturing scales up. The medication received MHRA approval in 2023, and as more pharmacies gain access to supply and patient demand stabilises, modest price reductions may occur industry-wide. However, the complex manufacturing process for tirzepatide and ongoing high demand suggest prices will remain in the £124.99-160 monthly range for the foreseeable future[8].

Supply constraints have periodically affected Mounjaro availability across UK pharmacies, sometimes creating temporary price increases. At Cured Pharmacy, we maintain consistent Mounjaro pricing at £124.99 regardless of supply fluctuations, with our £20 discount code Weightlossnew always available for first-time customers. We work directly with licensed wholesalers to secure reliable stock of genuine Eli Lilly manufactured Mounjaro.

Potential NHS coverage could dramatically change Mounjaro pricing accessibility for eligible patients in future. NICE is currently evaluating tirzepatide for obesity treatment, and if approved for NHS use, patients might access it for standard prescription charges (currently £124.99 per item). However, NHS availability would likely be restricted to patients meeting strict BMI and comorbidity criteria. Private prescription access ensures availability for all clinically suitable patients regardless of NHS eligibility criteria.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Public Assessment Report. MHRA. [accessed 13 August 2026]
2. Eli Lilly and Company. (2023). Mounjaro (tirzepatide) injection: Prescribing information. Eli Lilly and Company. [accessed 13 August 2026]
3. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): A double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. [accessed 13 August 2026]
4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 13 August 2026]
5. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2): A randomised, open-label, phase 3 trial. The Lancet, 398(10300), 503-515. [accessed 13 August 2026]
6. Garvey, W. T., Frias, J. P., Jastreboff, A. M., et al. (2023). Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): A double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. The Lancet, 402(10402), 613-626. [accessed 13 August 2026]
7. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. [accessed 13 August 2026]
8. National Institute for Health and Care Excellence. (2024). Tirzepatide for managing overweight and obesity [ID6174]: Final scope. NICE. [accessed 13 August 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.